Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H30ClFN2O |
Molecular Weight | 452.991 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](N(C)C(=O)CC1(CCN(C)CC1)C2=CC=C(F)C=C2)C3=C4C=CC=CC4=CC(Cl)=C3
InChI
InChIKey=DRXBWLBZWAJIEF-IBGZPJMESA-N
InChI=1S/C27H30ClFN2O/c1-19(25-17-22(28)16-20-6-4-5-7-24(20)25)31(3)26(32)18-27(12-14-30(2)15-13-27)21-8-10-23(29)11-9-21/h4-11,16-17,19H,12-15,18H2,1-3H3/t19-/m0/s1
Molecular Formula | C27H30ClFN2O |
Molecular Weight | 452.991 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
GlaxoSmithKline was developing GSK-424887as a dual antagonist of the human neurokinin receptor 1 and inhibitor of the serotonin transporter. GSK 424887 participated in phase I clinical trials for the treatment of depressive disorder and anxiety disorder. However, further development of GSK 424887 apparently was discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01059591
GSK424887 2mg, 10mg, 50mg, 100mg capsule.Once daily
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:23:37 GMT 2023
by
admin
on
Sat Dec 16 09:23:37 GMT 2023
|
Record UNII |
IYI99KCF2T
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
76958276
Created by
admin on Sat Dec 16 09:23:37 GMT 2023 , Edited by admin on Sat Dec 16 09:23:37 GMT 2023
|
PRIMARY | |||
|
300000041360
Created by
admin on Sat Dec 16 09:23:37 GMT 2023 , Edited by admin on Sat Dec 16 09:23:37 GMT 2023
|
PRIMARY | |||
|
DB12219
Created by
admin on Sat Dec 16 09:23:37 GMT 2023 , Edited by admin on Sat Dec 16 09:23:37 GMT 2023
|
PRIMARY | |||
|
IYI99KCF2T
Created by
admin on Sat Dec 16 09:23:37 GMT 2023 , Edited by admin on Sat Dec 16 09:23:37 GMT 2023
|
PRIMARY |